Allecra   Report issue

For profit Phase 1 Phase 3
Founded: Weil Am Rhein Germany (2013)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
2013
NCT03685084
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Allecra

Active Ingredients

Drugs in Phase 3 Trials (4)

cefepime (maxipeme) (6 trials)

Enmetazobactam (7 trials)

piperacillin (pipracil) (2 trials)

tazobactam (Zosyn) (1 trial)

Drugs in Phase 1 Trials (1)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 3)

Infections (Phase 3)

Renal Insufficiency (Phase 1)

Urinary Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 5